Olema Oncology: Funding, Investors & Team (Sep 2026)
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company focuses on the discovery, development, and commercialization of targeted therapies for women's cancers. It leverages the knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development. Olema leverages their deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance with the goal of transforming the standard of care for pre- and post-menopausal women living with cancer by developing more convenient and effective therapies.
Olema Oncology has raised $570M across 3 funding rounds on record, the most recent an undisclosed round of $190M announced in Nov 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Olema Oncology Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Olema Oncology Funding Rounds
Olema Oncology raised $130M in an undisclosed round announced in Sep 2023.
1.3 years later, an undisclosed round of $250M was announced in Dec 2024.
11 months later, an undisclosed round of $190M was announced in Nov 2025.
Olema Oncology Founders and Leadership Team
No contact details are on record for this team yet.
Olema Oncology Funding Compared to Other Biotechnology Startups
Olema Oncology's latest round of $190M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Olema Oncology in Biotechnology and San Francisco
Companies Similar to Olema Oncology
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Olema Oncology Funding FAQs
What does Olema Oncology do?
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company focuses on the discovery, development, and commercialization of targeted therapies for women's cancers. It leverages the knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development. Olema leverages their deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance with the goal of transforming the standard of care for pre- and post-menopausal women living with cancer by developing more convenient and effective therapies.
How much funding has Olema Oncology raised?
Olema Oncology has raised $570M across 3 rounds on record. The most recent is an undisclosed round of $190M announced in Nov 2025.
When did Olema Oncology last raise funding?
Olema Oncology's most recent funding round on record is an undisclosed round of $190M, announced in Nov 2025.
Who founded Olema Oncology?
FundedIQ lists Peter Kushner (Founder) at Olema Oncology.
Where is Olema Oncology headquartered?
Olema Oncology is based in San Francisco, California, United States.
How many employees does Olema Oncology have?
Olema Oncology is in the 51-100 employee band.
How does Olema Oncology's funding compare to other Biotechnology startups?
Olema Oncology's latest round of $190M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Olema Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Olema Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.